Illumina
$118.94
459
+$3.38+2.92% Friday 20:00
Statistics
Day High
120.41
Day Low
116.1
52W High
155.53
52W Low
68.7
Volume
1,768,558
Avg. Volume
2,064,116
Mkt Cap
18.19B
P/E Ratio
27.7
Dividend Yield
-
Dividend
-
Upcoming
Earnings
28AprExpected
Expected EPS
1.060557
Actual EPS
N/A
Financials
19.57%Profit Margin
Profitable8.69BRevenue
1.7BNet Income
Analyst Ratings
$138.38Average Price Target
The highest estimate is 170.00.
From 8 ratings within the last 6 months. This is not an investment recommendation.
From 8 ratings within the last 6 months. This is not an investment recommendation.
Buy 38%
Hold 50%
Sell 13%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow ILMN. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Pacific Biosciences of California
PACB
Mkt Cap702.87M
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Bio-Rad Laboratories
BIO.B
Mkt Cap8.84B
Qiagen NV
QGEN
Mkt Cap10.16B
Roche
RHHBY
Mkt Cap258.9B
Agenus
AGEN
Mkt Cap126.5M
Intellia Therapeutics
NTLA
Mkt Cap1.35B
Editas Medicine
EDIT
Mkt Cap276.95M
CRISPR Therapeutics
CRSP
Mkt Cap5.82B
About
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.
Show more...
CEO
Mr. Jacob Thaysen Ph.D.
Employees
8970
Country
US
ISIN
US4523271090
Listings
0 Comments
Share your thoughts
FAQ
What is Illumina stock price today?▼
The current price of ILMN is $118.94 USD — it has increased by +2.92% in the past 24 hours. Watch Illumina stock price performance more closely on the chart.
What is Illumina stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Illumina stocks are traded under the ticker ILMN.
Is Illumina stock price growing?▼
ILMN stock has fallen by -4.3% compared to the previous week, the month change is a +1.82% rise, over the last year Illumina has showed a +38.95% increase.
What is Illumina market cap?▼
Today Illumina has the market capitalization of 18.19B
When is the next Illumina earnings date?▼
Illumina is going to release the next earnings report on April 28, 2026.
What were Illumina earnings last quarter?▼
ILMN earnings for the last quarter are 1.35 USD per share, whereas the estimation was 1.24 USD resulting in a +8.7% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Illumina revenue for the last year?▼
Illumina revenue for the last year amounts to 8.69B USD.
What is Illumina net income for the last year?▼
ILMN net income for the last year is 1.7B USD.
How many employees does Illumina have?▼
As of March 16, 2026, the company has 8,970 employees.
In which sector is Illumina located?▼
Illumina operates in the Health Care sector.
When did Illumina complete a stock split?▼
The last stock split for Illumina was on September 23, 2008 with a ratio of 2:1.
Where is Illumina headquartered?▼
Illumina is headquartered in San Diego, US.